Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Viral mutation in Japan may render vaccine ineffective. Source. Global Times
Press are reporting that the crucial 1000 cases per day has just been
passed for the first time since June........I can see another Lockdown
to try and get schools open in September.......
Some great posts this afternoon, good to see debate with substance....!
GLA!
The important point with the SNG treatment, it has a shelf life of 36 months, I believe. That's important, especially with all the short-termism of the innoculation process, which does not cover all the permutations of the virus.
Sad thing here is that lots of suppliers have profited massively out of PPE (rushed and not up to standard),ventilators hiked up, hospitals popped up all over the world. Money was no object to get supply. I doubt any government was truly prepared for the scale of this pandemic. They need to be stockpiling across the UK, Europe, America's, Africa, Asia for the next 12 months. SNG might be the light at the end of the tunnel. If they're purchasing unproven vaccines they should also be stockpiling SNG, especially when/if the COPD trials produce positive results.support
Reckon Boris would commit to a couple of billion pounds worth of doses to treat UK sufferers. US five times our population, Europe another 4/5 times in the most affected areas, India and Africa even more multiples. The order book would be huge so needs huge production and distribution support. World wide licensing sounds like the way to go for me
Don't get me wrong I pay no attention to the media. Their reporting of the initial results by SNG001 were awful and frankly derogatory to RM and the team. All about them getting rich rather than having spent 10 or 15 years developing a treatment which may be of massive help to the world whether for this virus or other conditions.
Having said that, it's not beyond governments to use the media to paint the picture of any drug company, large or small of exploiting people for profit, and that'd be doubly impactful in a pandemic. So I've no doubt SNG or the major on their behalf will try to make the most money from this but at the very same type they'll be treading a tightrope with regards to pricing. I'm certainly not saying they can't make good money.
Hi Rich
There are so many ways this could play out..But I saw Richard Marsden Interviewed
on Sky News by Kay Burley on the day of results. She tried very hard to push him on
what SNG001 may cost per treatment..He steadfastly refused to be drawn on the topic...
Philanthropy is a wonderful thing..and I am plaesed to see the majors taking a view
on the costs of vaccines...But they will more than cover their costs. IMHO..
I do not think we are under pressure...we may take a view on Covid...But
we need to make a profit to fund further trials ...As shareholders I think
we would be rightly disappointed not to profit from our first breakthrough..
No one in the industry would expect a minnow to behave like a big fish...IMHO!
Manifesto - I think they will have to price it "right" so I don't think his comment is unfair. Remdesivir is $2,340 for a 5 day course and they're being pressured by governments on that. Obviously ever government would haggle (and will) but I don't see any reason they couldn't be aiming for $1000 or $2000 for a course of SNG001 without risking too much push-back.
This is also part of why I think a deal for SNG001 will be a profit-sharing / milestone type deal. Nobody knows how long coronavirus will be around, whether due to vaccines in future years, or because it's got under control enough (whether in the richest western markets or elsewhere). Or because another treatment (or vaccine-like product) appears from somewhere else. It's something of a moving target for the major making it harder to justify big initial outlays and easier to justify allowing SNG to retain a certain percentage of the profit so everyone wins if it's used a lot.
Imho should SNG001 reach the market(s) it will be left to Synairgen’s licensee(s) or acquirer to determine any price as Synairgen has no capability/ infrastructure to go it alone.
Remdesivir price is ...
Ascottmatt.....Major pharmas make billions in profit..
We are a small AIM company.......We are free to set
our pricing accordingly......We have worked for 15 years
for a commercial breakthrough.....I do not think
we will be under any pressure to follow the majors....
With all the talk about Vaccines, it's worth mentioning that some of the makers are pledging not to take huge profits, AstraZenica and others have offered potential vaccines at cost in the US while the National Emergency exists (but not after), meanwhile the worlds largest vaccine manufacturer is suggesting a price cap of $3 (that's a cap, so can be much less in the developing world).
SNG will be under similar pressure not to price any treatment at too high a rate, will still make money but not thousands of profit per patient that has been mooted previously.